(c) 2024 PillSync.com

KTab 10 MEQ Extended Release Tablet

INDICATIONS AND USAGE BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS, OR FOR PATIENTS WITH WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. For the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias. The use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern, and when low doses of the diuretic are used. Serum potassium should be checked periodically, however, and, if hypokalemia occurs, dietary supplementation with potassium-containing foods may be adequate to control milder cases. In more severe cases and if dose adjustment of the diuretic is ineffective or unwarranted supplementation with potassium salts may be indicated.

Aphena Pharma Solutions - Tennessee, Inc.


10 years ago OVAL YELLOW KTAB a KTab 10 MEQ Extended Release Tablet

OVAL YELLOW KTAB a

HOW SUPPLIED Repackaged by Aphena Pharma Solutions - TN. See Repackaging Information for available configurations. K-TAB (potassium chloride extended-release tablets, USP) contain 750 mg and 1500 mg of potassium chloride (equivalent to 10 mEq and 20 mEq, respectively). K-TAB tablets are provided as ovaloid, extended-release Filmtab ® tablets. K-TAB 750 mg are yellow in color and are debossed with the “a” logo on one side and the trademark K-TAB on the other side. K-TAB 1500 mg are white in color and are debossed with the trademark K-TAB on one side. K-TAB Tablets are supplied as follows: 10 mEq Bottles of 30 NDC 0074-7804-30 Bottles of 90 NDC 0074-7804-90 Bottles of 100 NDC 0074-7804-13 Bottles of 1000 NDC 0074-7804-19 Bottles of 5000 NDC 0074-7804-59 Unit dose packages of 100 NDC 0074-7804-11 20 mEq Bottles of 30 NDC 0074-3023-30 Bottles of 90 NDC 0074-3023-90 Bottles of 100 NDC 0074-3023-13 Bottles of 500 NDC 0074-3023-53 Recommended Storage Do not store above 77°F (25°C). Filmtab ® - Film-sealed tablets, AbbVie Inc. ©2013 AbbVie Inc. Manufactured by: AbbVie LTD Barceloneta, PR 00617 For: AbbVie Inc. North Chicago, IL 60064 03-A823 November, 2013


More pills like OVAL KTAB a

Related Pills

KTab 10 MEQ Extended Release Tablet

Aphena Pharma Solutions - Tennessee, Inc.

ktab potassium chloride tablet film coated extended release

aphena pharma solutions - tennessee, llc

KTab 10 MEQ Extended Release Tablet

Aphena Pharma Solutions - Tennessee, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site